Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PGK1 | P00558 | 1/20 | 0.57 |
| ▸ | PGK2 | P07205 | 1/20 | 0.57 |
| ▸ | PGD | P52209 | 5/20 | 0.53 |
| ▸ | MPI | P34949 | 1/20 | 0.39 |
| ▸ | LAP3 | P28838 | 2/20 | 0.37 |
| ▸ | PIN1 | Q13526 | 1/20 | 0.35 |
| ▸ | TPI1 | P60174 | 1/20 | 0.34 |
| ▸ | LPAR6 | P43657 | 1/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 1/20 | 0.33 |
| ▸ | LPAR4 | Q99677 | 1/20 | 0.33 |
| ▸ | LPAR5 | Q9H1C0 | 1/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 1/20 | 0.33 |
| ▸ | LPAR3 | Q9UBY5 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4404352 | 1.00 | PGK1 (0.57) | PGK1PGK2PGDMPILAP3 | |
| SCHEMBL80335 | 1.00 | PGK1 (0.57) | PGK1PGK2PGDMPILAP3 | |
| SCHEMBL31657225 | 0.98 | PGK1 (0.55) | PGK1PGK2PGDMPILAP3 | |
| Phosphoric Acid SCHEMBL5917775 | 0.98 | PGK1 (0.55) | PGK1PGK2PGDMPILAP3 | |
| SCHEMBL3488353 | 0.89 | PGK1 (0.45) | PGK1PGK2PGDLAP3 | |
| SCHEMBL13176646 | 0.86 | PGK1 (0.52) | PGK1PGK2PGDMPILAP3 | |
| SCHEMBL186958 | 0.84 | PGK1 (0.50) | PGK1PGK2PGDMPILAP3 | |
| SCHEMBL4867885 | 0.82 | PGK1 (0.44) | PGK1PGK2PGDMPILAP3 | |
| SCHEMBL7756355 | 0.81 | PGK1 (0.47) | PGK1PGK2PGDLAP3LPAR6 | |
| SCHEMBL14464207 | 0.78 | LAP3 (0.41) | PGK1PGK2PGDLAP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4587116-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2025-07-23 | — | — | EP | disclosed |
| WO-2024058984-A2 | METHODS AND USES OF MICROBIOME COMPOSITIONS, COMPONENTS, OR METABOLITES FOR TREATING INSULIN-ASSOCIATED DISEASES | MarvelBiome, Inc. (US) | 2024-03-21 | — | — | WO | disclosed |